Cellebrite DI (CLBT) UBS Global Technology and AI Conference summary
Event summary combining transcript, slides, and related documents.
UBS Global Technology and AI Conference summary
12 Jan, 2026Company overview and mission
Operates globally with $400 million ARR, 1,100 employees, and a $4 billion market cap.
Provides digital forensics solutions to law enforcement and government agencies worldwide.
Focuses on extracting, decoding, and analyzing digital evidence from mobile devices and computers.
Holds a 50% market share in digital mobile forensics, serving the full investigation workflow.
Recognized for deep expertise in mobile device access and data analysis since 2008.
Leadership transition
Founder and long-time CEO stepped down after 19 years, citing the company’s strong position.
Transition aims to bring new leadership to scale ARR beyond $1 billion.
Executive chairman is actively involved to ensure continuity until a new CEO is appointed in early 2025.
Technology differentiation and innovation
Offers end-to-end digital investigation solutions, not just point products.
Inseyets platform, launched in January, doubles extraction speed and increases data capture by 50%.
Pathfinder leverages AI and machine learning, now available as a cloud-based SaaS solution.
Continuous innovation to keep pace with device encryption and privacy advancements.
Cloudification democratizes access, enabling smaller agencies to use advanced tools.
Latest events from Cellebrite DI
- AI-driven digital forensics platform accelerates growth with cloud migration and new product launches.CLBT
Morgan Stanley Technology, Media & Telecom Conference 20263 Mar 2026 - 2025 delivered 21% ARR growth, strong margins, and a robust 2026 growth outlook.CLBT
Q4 202511 Feb 2026 - Growth is fueled by digital investigation platform expansion, cloud, and AI innovation.CLBT
Bank of America Global Technology Conference 20253 Feb 2026 - Strong platform, AI innovation, and cloud growth drive solid financial outlook and market expansion.CLBT
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Q2 revenue up 25%, ARR up 26%, with raised 2024 guidance and strong federal, AI momentum.CLBT
Q2 20241 Feb 2026 - Q3 2024 set records for revenue and ARR, with raised guidance and a CEO transition announced.CLBT
Q3 202416 Jan 2026 - Q1 revenue up 20% and ARR up 23%, with strong profitability and global expansion.CLBT
Q1 20258 Jan 2026 - Q3 revenue up 18% to $126M, ARR up 19%, and Corellium deal to boost future growth.CLBT
Q3 20256 Jan 2026 - 25% ARR growth and strong margins in 2024, with 2025 guidance for continued expansion.CLBT
Q4 20246 Jan 2026